Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,743 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A randomized study of the immunogenicity and safety of Japanese encephalitis chimeric virus vaccine (JE-CV) in comparison with SA14-14-2 vaccine in children in the Republic of Korea.
Kim DS, Houillon G, Jang GC, Cha SH, Choi SH, Lee J, Kim HM, Kim JH, Kang JH, Kim JH, Kim KH, Kim HS, Bang J, Naimi Z, Bosch-Castells V, Boaz M, Bouckenooghe A. Kim DS, et al. Among authors: kim hm, kim hs, kim kh, kim jh. Hum Vaccin Immunother. 2014;10(9):2656-63. doi: 10.4161/hv.29743. Epub 2014 Nov 6. Hum Vaccin Immunother. 2014. PMID: 25483480 Free PMC article. Clinical Trial.
Immunogenicity and Safety of a Booster Dose of a Live Attenuated Japanese Encephalitis Chimeric Vaccine Given 1 Year After Primary Immunization in Healthy Children in the Republic of Korea.
Kim DS, Jang GC, Cha SH, Choi SH, Kim HM, Kim JH, Kang JH, Kim JH, Kim KH, Bang J, Naimi Z, Bouckenooghe A, Bosch-Castells V, Houillon G. Kim DS, et al. Among authors: kim hm, kim kh, kim jh. Pediatr Infect Dis J. 2016 Feb;35(2):e60-4. doi: 10.1097/INF.0000000000000967. Pediatr Infect Dis J. 2016. PMID: 26535878 Clinical Trial.
Safety and immunogenicity of a single dose of a quadrivalent meningococcal conjugate vaccine (MenACYW-D): a multicenter, blind-observer, randomized, phase III clinical trial in the Republic of Korea.
Kim DS, Kim MJ, Cha SH, Kim HM, Kim JH, Kim KN, Lee JS, Choi JY, Castells VB, Kim HS, Bang J, Oster P. Kim DS, et al. Among authors: kim kn, kim hm, kim hs, kim mj, kim jh. Int J Infect Dis. 2016 Apr;45:59-64. doi: 10.1016/j.ijid.2016.02.010. Epub 2016 Feb 24. Int J Infect Dis. 2016. PMID: 26921548 Free article. Clinical Trial.
4,743 results